MedCap AB Ownership

MCAP Stock  SEK 524.00  7.00  1.32%   
The market capitalization of MedCap AB is kr3.57 Billion. MedCap AB holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedCap AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

MedCap Stock Ownership Analysis

About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of MedCap AB was now reported as 57.83. The company has Price/Earnings (P/E) ratio of 197.02. MedCap AB recorded earning per share (EPS) of 7.98. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 27th of September 2016. MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. MedCap AB was founded in 2001 and is based in Stockholm, Sweden. MedCap AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange. To find out more about MedCap AB contact the company at 46 8 34 71 10 or learn more at https://www.medcap.se.

MedCap AB Outstanding Bonds

MedCap AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MedCap AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MedCap bonds can be classified according to their maturity, which is the date when MedCap AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MedCap Stock Analysis

When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.